AAPL349.51+17.61 (+5.31%) ▲|ABBV294.83+8.83 (+3.09%) ▲|ABT115.51+6.11 (+5.59%) ▲|ACN264.27+9.71 (+3.81%) ▲|ADBE248.48+2.34 (+0.95%) ▲|AMAT369.40-12.52 (-3.28%) ▼|AMD488.78+4.88 (+1.01%) ▲|AMGN478.48+17.22 (+3.73%) ▲|AMT194.86+7.57 (+4.04%) ▲|AMZN266.03+15.34 (+6.12%) ▲|AVGO325.48-6.65 (-2.00%) ▼|AXP332.59+7.09 (+2.18%) ▲|BA177.00+3.69 (+2.13%) ▲|BAC51.63+1.97 (+3.97%) ▲|BKNG170.97+15.30 (+9.83%) ▲|BLK1,224.37+63.05 (+5.43%) ▲|BMY64.19+2.48 (+4.02%) ▲|BNY152.72+3.41 (+2.28%) ▲|BRK-B579.09+22.02 (+3.95%) ▲|C124.74+2.03 (+1.65%) ▲|CAT591.30-32.64 (-5.23%) ▼|CL98.76+3.14 (+3.28%) ▲|CMCSA24.85+1.18 (+4.99%) ▲|COF206.31-2.40 (-1.15%) ▼|COP136.94-7.46 (-5.17%) ▼|COST1,046.47+27.21 (+2.67%) ▲|CRM227.11+4.91 (+2.21%) ▲|CSCO103.61+0.64 (+0.62%) ▲|CVS79.96-11.45 (-12.53%) ▼|CVX216.96-8.31 (-3.69%) ▼|DE676.50+10.67 (+1.60%) ▲|DHR234.93+4.82 (+2.09%) ▲|DIS118.95+4.77 (+4.18%) ▲|DUK129.59+3.08 (+2.43%) ▲|EMR170.44+4.05 (+2.43%) ▲|FDX329.40+11.38 (+3.58%) ▲|GD364.87-9.63 (-2.57%) ▼|GE329.45+8.78 (+2.74%) ▲|GEV832.83-85.37 (-9.30%) ▼|GILD174.48+7.01 (+4.19%) ▲|GM92.43+4.09 (+4.63%) ▲|GOOG287.30+9.03 (+3.25%) ▲|GOOGL288.93+8.90 (+3.18%) ▲|GS928.00+31.91 (+3.56%) ▲|HD355.44+21.78 (+6.53%) ▲|HON228.47+4.42 (+1.97%) ▲|IBM254.32+4.28 (+1.71%) ▲|INTC58.27-2.28 (-3.77%) ▼|INTU356.64+11.92 (+3.46%) ▲|ISRG482.10+41.35 (+9.38%) ▲|JNJ276.32+10.15 (+3.81%) ▲|JPM352.11+14.13 (+4.18%) ▲|KO95.80+1.00 (+1.05%) ▲|LIN524.74+13.19 (+2.58%) ▲|LLY1,417.99+8.61 (+0.61%) ▲|LMT595.04-43.96 (-6.88%) ▼|LOW229.38+16.00 (+7.50%) ▲|LRCX221.43-9.29 (-4.03%) ▼|MA672.68+25.50 (+3.94%) ▲|MCD280.22+17.18 (+6.53%) ▲|MDLZ67.38+2.26 (+3.47%) ▲|MDT104.96+6.08 (+6.15%) ▲|META630.00+8.97 (+1.44%) ▲|MMM193.95+16.90 (+9.55%) ▲|MO78.01+1.07 (+1.39%) ▲|MRK150.36+5.69 (+3.93%) ▲|MS193.97+7.88 (+4.23%) ▲|MSFT555.80+34.81 (+6.68%) ▲|MU795.23-59.87 (-7.00%) ▼|NEE88.45+4.12 (+4.89%) ▲|NFLX66.39+2.97 (+4.68%) ▲|NKE40.49+2.01 (+5.22%) ▲|NOW108.81-0.35 (-0.32%) ▼|NVDA200.13-6.56 (-3.17%) ▼|ORCL123.73-2.46 (-1.95%) ▼|PEP142.42+5.15 (+3.75%) ▲|PFE30.79+0.79 (+2.63%) ▲|PG167.32+5.26 (+3.25%) ▲|PLTR171.70-3.70 (-2.11%) ▼|PM211.28+3.25 (+1.56%) ▲|QCOM173.19+8.76 (+5.33%) ▲|RTX198.43-5.39 (-2.64%) ▼|SBUX109.70+4.93 (+4.71%) ▲|SCHW93.37+4.09 (+4.58%) ▲|SO93.12-0.63 (-0.67%) ▼|SPG228.50+6.42 (+2.89%) ▲|T21.83+0.44 (+2.06%) ▲|TMO706.16+7.82 (+1.12%) ▲|TMUS159.17+4.76 (+3.08%) ▲|TSLA385.19-13.31 (-3.34%) ▼|TXN311.49-1.00 (-0.32%) ▼|UBER69.87+3.27 (+4.91%) ▲|UNH409.38+4.94 (+1.22%) ▲|UNP308.53+5.10 (+1.68%) ▲|UPS114.31+5.14 (+4.71%) ▲|USB61.03+1.14 (+1.90%) ▲|V436.57+16.15 (+3.84%) ▲|VZ46.17+0.93 (+2.06%) ▲|WFC87.43+1.90 (+2.22%) ▲|WMT129.17+4.31 (+3.45%) ▲|XOM169.27-8.19 (-4.62%) ▼|AAPL349.51+17.61 (+5.31%) ▲|ABBV294.83+8.83 (+3.09%) ▲|ABT115.51+6.11 (+5.59%) ▲|ACN264.27+9.71 (+3.81%) ▲|ADBE248.48+2.34 (+0.95%) ▲|AMAT369.40-12.52 (-3.28%) ▼|AMD488.78+4.88 (+1.01%) ▲|AMGN478.48+17.22 (+3.73%) ▲|AMT194.86+7.57 (+4.04%) ▲|AMZN266.03+15.34 (+6.12%) ▲|AVGO325.48-6.65 (-2.00%) ▼|AXP332.59+7.09 (+2.18%) ▲|BA177.00+3.69 (+2.13%) ▲|BAC51.63+1.97 (+3.97%) ▲|BKNG170.97+15.30 (+9.83%) ▲|BLK1,224.37+63.05 (+5.43%) ▲|BMY64.19+2.48 (+4.02%) ▲|BNY152.72+3.41 (+2.28%) ▲|BRK-B579.09+22.02 (+3.95%) ▲|C124.74+2.03 (+1.65%) ▲|CAT591.30-32.64 (-5.23%) ▼|CL98.76+3.14 (+3.28%) ▲|CMCSA24.85+1.18 (+4.99%) ▲|COF206.31-2.40 (-1.15%) ▼|COP136.94-7.46 (-5.17%) ▼|COST1,046.47+27.21 (+2.67%) ▲|CRM227.11+4.91 (+2.21%) ▲|CSCO103.61+0.64 (+0.62%) ▲|CVS79.96-11.45 (-12.53%) ▼|CVX216.96-8.31 (-3.69%) ▼|DE676.50+10.67 (+1.60%) ▲|DHR234.93+4.82 (+2.09%) ▲|DIS118.95+4.77 (+4.18%) ▲|DUK129.59+3.08 (+2.43%) ▲|EMR170.44+4.05 (+2.43%) ▲|FDX329.40+11.38 (+3.58%) ▲|GD364.87-9.63 (-2.57%) ▼|GE329.45+8.78 (+2.74%) ▲|GEV832.83-85.37 (-9.30%) ▼|GILD174.48+7.01 (+4.19%) ▲|GM92.43+4.09 (+4.63%) ▲|GOOG287.30+9.03 (+3.25%) ▲|GOOGL288.93+8.90 (+3.18%) ▲|GS928.00+31.91 (+3.56%) ▲|HD355.44+21.78 (+6.53%) ▲|HON228.47+4.42 (+1.97%) ▲|IBM254.32+4.28 (+1.71%) ▲|INTC58.27-2.28 (-3.77%) ▼|INTU356.64+11.92 (+3.46%) ▲|ISRG482.10+41.35 (+9.38%) ▲|JNJ276.32+10.15 (+3.81%) ▲|JPM352.11+14.13 (+4.18%) ▲|KO95.80+1.00 (+1.05%) ▲|LIN524.74+13.19 (+2.58%) ▲|LLY1,417.99+8.61 (+0.61%) ▲|LMT595.04-43.96 (-6.88%) ▼|LOW229.38+16.00 (+7.50%) ▲|LRCX221.43-9.29 (-4.03%) ▼|MA672.68+25.50 (+3.94%) ▲|MCD280.22+17.18 (+6.53%) ▲|MDLZ67.38+2.26 (+3.47%) ▲|MDT104.96+6.08 (+6.15%) ▲|META630.00+8.97 (+1.44%) ▲|MMM193.95+16.90 (+9.55%) ▲|MO78.01+1.07 (+1.39%) ▲|MRK150.36+5.69 (+3.93%) ▲|MS193.97+7.88 (+4.23%) ▲|MSFT555.80+34.81 (+6.68%) ▲|MU795.23-59.87 (-7.00%) ▼|NEE88.45+4.12 (+4.89%) ▲|NFLX66.39+2.97 (+4.68%) ▲|NKE40.49+2.01 (+5.22%) ▲|NOW108.81-0.35 (-0.32%) ▼|NVDA200.13-6.56 (-3.17%) ▼|ORCL123.73-2.46 (-1.95%) ▼|PEP142.42+5.15 (+3.75%) ▲|PFE30.79+0.79 (+2.63%) ▲|PG167.32+5.26 (+3.25%) ▲|PLTR171.70-3.70 (-2.11%) ▼|PM211.28+3.25 (+1.56%) ▲|QCOM173.19+8.76 (+5.33%) ▲|RTX198.43-5.39 (-2.64%) ▼|SBUX109.70+4.93 (+4.71%) ▲|SCHW93.37+4.09 (+4.58%) ▲|SO93.12-0.63 (-0.67%) ▼|SPG228.50+6.42 (+2.89%) ▲|T21.83+0.44 (+2.06%) ▲|TMO706.16+7.82 (+1.12%) ▲|TMUS159.17+4.76 (+3.08%) ▲|TSLA385.19-13.31 (-3.34%) ▼|TXN311.49-1.00 (-0.32%) ▼|UBER69.87+3.27 (+4.91%) ▲|UNH409.38+4.94 (+1.22%) ▲|UNP308.53+5.10 (+1.68%) ▲|UPS114.31+5.14 (+4.71%) ▲|USB61.03+1.14 (+1.90%) ▲|V436.57+16.15 (+3.84%) ▲|VZ46.17+0.93 (+2.06%) ▲|WFC87.43+1.90 (+2.22%) ▲|WMT129.17+4.31 (+3.45%) ▲|XOM169.27-8.19 (-4.62%) ▼|
17 C
New York
Thursday, November 5, 2026

Tag: company

Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announces that dosing has commenced at the prestigious Weill Cornell Medicine Multiple Sclerosis Center in New York City, in its ongoing Phase 2 clinical trial evaluating intranasal foralumab in patients with non-active Secondary Progressive Multiple Sclerosis (na-SPMS). This fifth site complements existing sites at Yale University, Johns Hopkins University, Brigham and Women's Hospital, and the University of Massachusetts.

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FTRE

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fortrea Holdings, Inc. (NASDAQ: FTRE) between July 3, 2023 and February 28, 2025, both dates inclusive (the “Class Period”), of the important August 1, 2025 lead plaintiff deadline.

LPRO Investors Have Opportunity to Lead Open Lending Corporation Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, June 13, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Open...

IoT Medical Devices Market worth US$154.74 billion by 2030 with 18.9% CAGR | MarketsandMarkets™.

DELRAY BEACH, Fla., June 13, 2025 /PRNewswire/ -- The global IoT Medical Devices Market, valued at US$53.78 billion in 2024 stood at US$65.08 billion in...

Everlight Solar Secures Comparably’s 2025 Best Sales Teams Award

VERONA, Wis., June 13, 2025 /PRNewswire/ -- Everlight Solar is proud to announce its recognition as one of Comparably's Best Sales Teams of 2025....

Leverage Shares by Themes continues product expansion with a new single stock leveraged ETF, bringing investors an exciting opportunity to amplify exposure to Boeing...

GREENWICH, Conn., June 13, 2025 (GLOBE NEWSWIRE) -- Leverage Shares by Themes, an issuer of innovative exchange-traded products, is excited to announce the launch of the Leverage Shares 2X long BA Daily ETF (ticker: BOEG), a new single stock leveraged ETF, available for trading starting June 13, 2025 on Nasdaq. The product is designed to equip investors to amplify returns (up and down) and dynamically participate in the performance of a leading transportation and aerospace company. The new ETF is tailored to target a 200% exposure to the daily performance of its underlying stock, Boeing Co. (BA), offering sophisticated traders and the retail investor an efficient tool to capitalize on market movements at an industry low management fee for single stock leveraged ETFs at .75%.

Air Products to Showcase Industrial Gas Solutions at the PowderMet2025 International Conference on Powder Metallurgy and Particulate Materials

LEHIGH VALLEY, Pa., June 13, 2025 /PRNewswire/ -- Air Products (NYSE:APD) will showcase industrial gas solutions and technologies for metals and materials processing applications...

New Report: 5.1% Growth Expected for Auto Care Industry in 2025, Reaching $664 Billion in 2028

Auto Care Association releases 2026 Auto Care Factbook report detailing steady growth in the global aftermarket industry despite recent economic and trade uncertainties. BETHESDA, Md.,...

Enliven Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

BOULDER, Colo., June 13, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery...

Regarding the investment in the share capital of UAB “Ateities ūkis”

In order to promote the production of raw milk in Lithuania, AB "Rokiškio sūris" has invested EUR 10 million in to the authorized capital of UAB "Ateities ūkis" by acquiring 29.67 per cent of the authorized capital. UAB "Ateities ūkis" is a company belonging to the Agrokoncernas group, one of the main activities of which is the production of raw milk. In the opinion of the management of AB Rokiškio sūris, this transaction is beneficial for the company, as it will ensure an increase in the production of high-quality raw milk in Lithuania. The Management is also confident that the transaction is financially secure and will not have a significant impact on the company's performance and financial situation.

CCTV Focus! Multiple Strategic Agreements Signed! Central New Energy (01735.HK) Makes a Splash at SNEC 2025

SHANGHAI, June 13, 2025 /PRNewswire/ -- SNEC 2025 was grandly held at the National Exhibition and Convention Center (Shanghai) from June 11-13, 2025. Central New...

First Bancorp Announces Cash Dividend

SOUTHERN PINES, N.C., June 13, 2025 /PRNewswire/ -- The Board of Directors of First Bancorp (NASDAQ: FBNC) (the "Company"), the parent company of First Bank,...

13171229 B.C. Ltd. and Launchit Solutions Inc. Announce Execution of Business Combination Agreement and Launchit’s Concurrent Financing

VANCOUVER, British Columbia, June 13, 2025 (GLOBE NEWSWIRE) -- 1317229 B.C. Ltd. (“131” or the “Company”) and Launchit Solutions Inc. (“Launchit”) are pleased to announce that the Company, Launchit and 1001240330 Ontario Inc. (“Subco”), a wholly-owned subsidiary of the Company, have entered into a business combination agreement dated June 12, 2025 (the “Business Combination Agreement”) pursuant to which the Company will acquire Launchit by way of a three-cornered amalgamation, which will result in the reverse takeover of 131 by Launchit (the “Proposed Transaction”). Upon completion of the Proposed Transaction, the Company will continue to carry on the business of Launchit (thereafter referred to as the “Resulting Issuer”).

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCompany